Skip to main content
. 2021 Jan 14;11:1275. doi: 10.1038/s41598-020-79843-5

Table 2.

Biomarkers in blood of the study groups.

Blood biomarkers Survivor group (n = 49) Nor-survivor group (n = 17) Total (n = 66) P value
Inflammation
hs-CRP (mg/L), median (IQR) 188.3 (102.9–295.7) 175.7 (136.5–300.2) 187.9 (129.8–296.8) 0.849
PCT (ng/ml), median (IQR) 28.0 (6.1–95.3) 29.0 (10.8–102.4) 28.5 (6.3–97.1) 0.961
IL-6 (pg/ml), median (IQR) 217.6 (103.3–962.4) 4809.0 (247.2–5000.0) 313.7 (121.3–2565.3) 0.001*
Circulation
Lactate (mmol/l), median (IQR) 2.4 (1.8–3.2) 6.3 (2.5–14.3) 2.5 (1.9–4.1) 0.014*
NT-proBNP (ng/ml), median (IQR) 1596.5 (1708.6–10,635.4) 32,905.3 (17,942.5–35,000.0) 3720.1 (880.9–23,665.7) < 0.001*
Tn-I (ng/ml), median (IQR) 0.0 (0.01–0.12) 0.2 (0.01–0.98) 0.01 (0.01–0.31) 0.953
Renal function
Cr (μmol/l), median (IQR) 125.0 (92.0–247.0) 252.0 (239.0–463.0) 170.0 (103.0–281.0) 0.215
Liver function
Total bilirubin (μmol/l), median (IQR) 13.8 (5.0–70.9) 14.8 (8.3–110.9) 14.0 (6.0–88.9) 0.505
Coagulation function
PLT (× 109/l), mean (SD) 170.6 (109.5) 167.4 (110.5) 169.7 (108.0) 0.919
PT (s), median (IQR) 15.6 (13.2–17.4) 20.1 (16.9–25.2) 16.2 (14.0–19.5) 0.030*
APTT (s), median (IQR) 45.1 (38.5–55.3) 59.0 (46.8–90.5) 49.0 (42.2–58.0) 0.026*
Fib (g/l), median (IQR) 5.1 (4.2–7.7) 5.7 (2.2–6.2) 5.1 (4.1–7.3) 0.882
INR, median (IQR) 1.3 (1.1–1.5) 1.8 (1.5–3.8) 1.4 (1.2–1.8) < 0.001*
d-Dimer (μg/l), median (IQR) 3948.5 (2093.5–7848.0) 8889.4 (4278.9–10,000.0) 4765.9 (2792.7–8716.9) 0.717

IQR range interquartile, hs-CRP high-sensitivity C-reactive protein, PCT procalcitonin, IL-6 Interleukin 6, NT-proBNP N-terminal prohormone of brain natriuretic peptide, Tn-I Troponin I, Cr creatinine, PLT Platelet, PT prothrombin time, APTT activated partial thrombin time, Fib fibrinogen, INR international normalized ratio.

*Indicates a significant value, P < 0.05.